PRESS RELEASE published on 04/10/2026 at 10:00, 1 month 17 days ago Eckert & Ziegler Secures Patient Access to Critical Eye Cancer Treatment with MDR Certification for Ru-106 Eye Applicators Eckert & Ziegler obtains MDR certification for Ru-106 Eye Applicators, securing patient access to critical eye cancer treatment. Milestone ensures long-term availability in EU Eckert & Ziegler MDR Certification Patient Access Eye Cancer Treatment Ru-106 Eye Applicators
BRIEF published on 03/27/2026 at 09:06, 2 months ago Eckert & Ziegler SE: Strong Underlying Momentum and Growth Prospects Buy Recommendation Eckert & Ziegler Radiopharma Growth Isotope Sales Lu-177 & Ac-225
PRESS RELEASE published on 03/27/2026 at 09:01, 2 months ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY NuWays AG's research report upgrades Eckert & Ziegler SE classification. Detailed analysis reveals stronger revenue and earnings growth prospects for 2026, backed by positive radiopharma developments and strategic flexibility NuWays AG Financial Analysis Earnings Growth Eckert & Ziegler SE Radiopharma
BRIEF published on 03/26/2026 at 07:50, 2 months 1 day ago Eckert & Ziegler Reports Robust 2025 Financial Performance and Optimistic 2026 Forecast Financial Performance Medical Segment Isotope Products 2025 Results 2026 Forecast
PRESS RELEASE published on 03/26/2026 at 07:45, 2 months 1 day ago Eckert & Ziegler: Strong FY 2025 with Positive Outlook Eckert & Ziegler SE achieved strong performance in FY 2025 with sales of €312.0 million and plans for approx. €320 million sales in 2026, alongside an adjusted EBIT of approx. €80 million Sales Growth Forecast Earnings Increase Eckert & Ziegler SE FY 2025
BRIEF published on 03/06/2026 at 10:41, 2 months 21 days ago Eckert & Ziegler Proposes €0.22 Dividend per Share for 2025 Annual General Meeting Investor Relations Eckert & Ziegler Dividend Proposal Financial Year 2025
PRESS RELEASE published on 03/06/2026 at 10:36, 2 months 21 days ago EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 Eckert & Ziegler SE plans dividend of €0.22 per share for 2025, subject to AGM approval. Detailed financial statements to be released on March 26, 2026 Shareholders Annual Financial Statements Dividend Eckert & Ziegler SE 2025 Financial Year
BRIEF published on 02/26/2026 at 07:05, 3 months 1 day ago Eckert & Ziegler Partners with Molecular Partners for Radio-DARPin Development Partnership Cancer Treatment Eckert & Ziegler Radiopharmaceuticals Radio-DARPin
PRESS RELEASE published on 02/26/2026 at 07:00, 3 months 1 day ago Eckert & Ziegler Enters Partnership with Molecular Partners to Support Development of Radio-DARPin Therapeutics Eckert & Ziegler SE partners with Molecular Partners to develop Radio-DARPin therapeutics, leveraging DARPin technology for cancer treatment with alpha emitters Partnership Eckert & Ziegler Therapeutics Radio-DARPin Molecular Partners
BRIEF published on 02/16/2026 at 11:05, 3 months 11 days ago Eckert & Ziegler and UJF Boost Actinium-225 Production Eckert & Ziegler Radiopharmaceuticals Production Increase Actinium-225 Global Supply
Published on 05/27/2026 at 09:30, 3 hours 16 minutes ago Caldwell Strengthens Consumer and Private Equity Capabilities with Addition of Gabino Stuyck in Madrid
Published on 05/27/2026 at 02:10, 10 hours 36 minutes ago Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 11 hours 1 minute ago Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 12 hours 21 minutes ago Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 14 hours 31 minutes ago LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/27/2026 at 12:37, 8 minutes ago The Platform Group: Q1 figures 2026 with significant increase in GMV, revenue and EBITDA
Published on 05/27/2026 at 12:30, 16 minutes ago Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Published on 05/27/2026 at 11:57, 49 minutes ago Construction Begins in Finsterwalde: LION Smart Delivers Battery Storage Containers for Partner Renoc’s Large-Scale Project
Published on 05/27/2026 at 11:51, 55 minutes ago Statement of transactions in own shares from May 18, 2026 to May 22, 2026
Published on 05/26/2026 at 18:39, 18 hours 6 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 19 hours 1 minute ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
